The d32–CCR5 polymorphism played a significant role in the progression of primary IgAN, with the nl/nl genotype being an independent protective factor for late progression towards end-stage renal disease (Berthoux et al., 2006). The gene discussed is CCR5; the disease is stage 5 chronic kidney disease.